IdentificationGeneric Name(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOLDrugBank Accession NumberDB07648BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL (DB07648)× CloseWeightAverage: 360.4091 Monoisotopic: 360.158625904 Chemical FormulaC21H20N4O2SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUSerine/threonine-protein kinase Chk1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassPyrrolesSub ClassSubstituted pyrrolesDirect ParentPhenylpyrrolesAlternative ParentsPyrrolo[2,3-d]pyrimidines / Secondary alkylarylamines / Aminopyrimidines and derivatives / Imidolactams / Benzene and substituted derivatives / Heteroaromatic compounds / Secondary alcohols / 1,2-diols / Azacyclic compounds / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives


 show 2 moreSubstituents1,2-diol / 2-phenylpyrrole / 3-phenylpyrrole / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Benzenoid / Heteroaromatic compound / Hydrocarbon derivative / Imidolactam / Monocyclic benzene moiety / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Primary alcohol / Pyrimidine / Pyrrolo[2,3-d]pyrimidine / Pyrrolopyrimidine / Secondary alcohol / Secondary aliphatic/aromatic amine / Secondary amine


 show 15 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal Descriptorspyrrolopyrimidine (CHEBI:41839) Affected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyTWEONIHFGKSPLC-MRXNPFEDSA-NInChIInChI=1S/C21H20N4O2/c26-12-16(27)11-22-20-18-17(14-7-3-1-4-8-14)19(15-9-5-2-6-10-15)25-21(18)24-13-23-20/h1-10,13,16,26-27H,11-12H2,(H2,22,23,24,25)/t16-/m1/s1IUPAC Name(2R)-3-({5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl}amino)propane-1,2-diolSMILES[H][C@](O)(CO)CNC1=C2C(NC(=C2C2=CC=CC=C2)C2=CC=CC=C2)=NC=N1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound4369435PubChem Substance99444119ChemSpider3571997ZINCZINC000006475920PDBe LigandDF2PDB Entries2broClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0275 mg/mLALOGPSlogP2.58ALOGPSlogP2.48ChemaxonlogS-4.1ALOGPSpKa (Strongest Acidic)12.27ChemaxonpKa (Strongest Basic)6.31ChemaxonPhysiological Charge1ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area94.06 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity106.67 m3·mol-1ChemaxonPolarizability38.77 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9902Blood Brain Barrier+0.871Caco-2 permeable-0.5937P-glycoprotein substrateNon-substrate0.5639P-glycoprotein inhibitor INon-inhibitor0.7941P-glycoprotein inhibitor IINon-inhibitor0.5406Renal organic cation transporterNon-inhibitor0.8582CYP450 2C9 substrateNon-substrate0.8155CYP450 2D6 substrateNon-substrate0.7522CYP450 3A4 substrateNon-substrate0.7002CYP450 1A2 substrateNon-inhibitor0.7163CYP450 2C9 inhibitorNon-inhibitor0.767CYP450 2D6 inhibitorNon-inhibitor0.7785CYP450 2C19 inhibitorNon-inhibitor0.6536CYP450 3A4 inhibitorNon-inhibitor0.6889CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5265Ames testNon AMES toxic0.6437CarcinogenicityNon-carcinogens0.871BiodegradationNot ready biodegradable0.9717Rat acute toxicity2.5901 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9449hERG inhibition (predictor II)Inhibitor0.5831  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Serine/threonine-protein kinase Chk1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionProtein serine/threonine kinase activitySpecific FunctionSerine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA. May also nega...Gene NameCHEK1Uniprot IDO14757Uniprot NameSerine/threonine-protein kinase Chk1Molecular Weight54433.115 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:24 / Updated at June 12, 2020 16:52 